Related Experiment Video

Updated: Jun 5, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Lipid-lowering therapy with statins for the primary and secondary prevention of cardiovascular disease

Joel A Lardizabal1, Prakash Deedwania

  • 1Division of Cardiology, Department of Medicine, University of California-San Francisco (Fresno Medical Education Program), Fresno, CA 93701, USA.

Cardiology Clinics
|January 25, 2011
PubMed

Insights

Cardiovascular disease (CVD) remains a leading cause of death globally. Lipid-modifying therapies, particularly statins, have improved outcomes, but optimal treatment strategies for high-risk patients are debated.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Cardiovascular disease (CVD) is the leading global cause of mortality.
  • Lipid-modifying therapies have significantly reduced CVD-related deaths.
  • Statins are the current standard for cholesterol management.

Purpose of the Study:

  • To review the evolution of lipid-modifying therapies for cardiovascular disease.
  • To discuss the role of statins in cholesterol management.
  • To examine the debate surrounding high-intensity statin therapy versus cholesterol level-focused approaches in high-risk individuals.

Main Methods:

  • Literature review of lipid-modifying agents.
  • Analysis of treatment guidelines and clinical trial outcomes.
  • Discussion of current therapeutic strategies and controversies.

Main Results:

  • Lipid-lowering agents have evolved from older drugs to highly effective statins.
  • Statins have become the cornerstone of cholesterol therapy.
  • The optimal initial treatment strategy for high-risk CVD patients is debated.

Conclusions:

  • Lipid-modifying therapy has transformed CVD treatment and mortality rates.
  • Statins represent a major advancement in cholesterol management.
  • Further discussion is needed on the best initial approach for high-risk CVD patients.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...